Qing Huang

机构：Beijing Institute of Technology, Fujian Medical University, University of Electronic Science and Technology of China, Sichuan Cancer Hospital, Second Affiliated Hospital of Fujian Medical University, Chongqing University of Technology, University of Science and Technology Beijing · ORCID：0009-0006-7241-751X

发表论文 72 篇 · 总被引 686 次 · h-index 15

代表论文

• CircCDK14 Promotes Tumor Progression and Resists Ferroptosis in Glioma by Regulating PDGFRA (2022 · International Journal of Biological Sciences · 被引 76)
• Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke (2022 · Clinical Lymphoma Myeloma & Leukemia · 被引 18)
• Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status (2022 · Advances in Therapy · 被引 15)
• Real-world treatment sequencing and healthcare costs among CLL/SLL patients treated with venetoclax (2021 · Current Medical Research and Opinion · 被引 10)
• Clinical and economic burden of tumor lysis syndrome among patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world US retrospective study (2022 · Journal of Managed Care & Specialty Pharmacy · 被引 8)
• Exploring Gender Disparities in Factors Influencing Colorectal Cancer Screening Compliance in Singapore (2024 · Asian Pacific Journal of Cancer Prevention · 被引 7)